Skip to main content
Journal cover image

PCV97 ECONOMIC VALUE OF NON-VKA ORAL ANTICOAGULANTS (NOAC) IN NON-VALVULAR ATRIAL FIBRILLATION (NVAF): A LITERATURE REVIEW OF GLOBAL HEALTH TECHNOLOGY ASSESSMENTS (HTA)

Publication ,  Conference
Lopes, RD; Berger, S; DiFusco, M; Kang, A; Russ, C; Afriyie, A; Earley, A; Mantovani, L
Published in: Value in Health
May 2019

Duke Scholars

Published In

Value in Health

DOI

ISSN

1098-3015

Publication Date

May 2019

Volume

22

Start / End Page

S136 / S136

Publisher

Elsevier BV

Related Subject Headings

  • Health Policy & Services
  • 4407 Policy and administration
  • 4203 Health services and systems
  • 3801 Applied economics
  • 1402 Applied Economics
  • 1117 Public Health and Health Services
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lopes, R. D., Berger, S., DiFusco, M., Kang, A., Russ, C., Afriyie, A., … Mantovani, L. (2019). PCV97 ECONOMIC VALUE OF NON-VKA ORAL ANTICOAGULANTS (NOAC) IN NON-VALVULAR ATRIAL FIBRILLATION (NVAF): A LITERATURE REVIEW OF GLOBAL HEALTH TECHNOLOGY ASSESSMENTS (HTA). In Value in Health (Vol. 22, pp. S136–S136). Elsevier BV. https://doi.org/10.1016/j.jval.2019.04.532
Lopes, R. D., S. Berger, M. DiFusco, A. Kang, C. Russ, A. Afriyie, A. Earley, and L. Mantovani. “PCV97 ECONOMIC VALUE OF NON-VKA ORAL ANTICOAGULANTS (NOAC) IN NON-VALVULAR ATRIAL FIBRILLATION (NVAF): A LITERATURE REVIEW OF GLOBAL HEALTH TECHNOLOGY ASSESSMENTS (HTA).” In Value in Health, 22:S136–S136. Elsevier BV, 2019. https://doi.org/10.1016/j.jval.2019.04.532.
Lopes RD, Berger S, DiFusco M, Kang A, Russ C, Afriyie A, et al. PCV97 ECONOMIC VALUE OF NON-VKA ORAL ANTICOAGULANTS (NOAC) IN NON-VALVULAR ATRIAL FIBRILLATION (NVAF): A LITERATURE REVIEW OF GLOBAL HEALTH TECHNOLOGY ASSESSMENTS (HTA). In: Value in Health. Elsevier BV; 2019. p. S136–S136.
Lopes, R. D., et al. “PCV97 ECONOMIC VALUE OF NON-VKA ORAL ANTICOAGULANTS (NOAC) IN NON-VALVULAR ATRIAL FIBRILLATION (NVAF): A LITERATURE REVIEW OF GLOBAL HEALTH TECHNOLOGY ASSESSMENTS (HTA).” Value in Health, vol. 22, Elsevier BV, 2019, pp. S136–S136. Crossref, doi:10.1016/j.jval.2019.04.532.
Lopes RD, Berger S, DiFusco M, Kang A, Russ C, Afriyie A, Earley A, Mantovani L. PCV97 ECONOMIC VALUE OF NON-VKA ORAL ANTICOAGULANTS (NOAC) IN NON-VALVULAR ATRIAL FIBRILLATION (NVAF): A LITERATURE REVIEW OF GLOBAL HEALTH TECHNOLOGY ASSESSMENTS (HTA). Value in Health. Elsevier BV; 2019. p. S136–S136.
Journal cover image

Published In

Value in Health

DOI

ISSN

1098-3015

Publication Date

May 2019

Volume

22

Start / End Page

S136 / S136

Publisher

Elsevier BV

Related Subject Headings

  • Health Policy & Services
  • 4407 Policy and administration
  • 4203 Health services and systems
  • 3801 Applied economics
  • 1402 Applied Economics
  • 1117 Public Health and Health Services